"Dr. Lemont and the Laboratory of Podiatric Pathology have long been recognized as leaders in the field of podiatric pathology, having built a tremendous reputation on their expertise and service," said CBLPath Chairman and Chief Executive Officer William Curtis. "Combining our organizations will enable us to provide the premier podiatric pathology service to the more than 13,000 practicing podiatrists nationwide."

After surveying our members, we found that the number one issue or topic of concern was finding strategic partnerships and building long term alliances.
continue reading

Cell-based assays provide one of the most valuable tools in drug discovery. They are routinely used in target validation, HTS campaigns, structure activity relationship analyses and ADMET studies. Many factors need to be considered in designing, developing and running relevant cell based assays to progress discovery programs. Significant advances continue to be made in assay design and cell supply processes that incorporate biologically relevant cell types and novel detection technologies. continue reading

Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) guidelines are in effect within their organization will have a thorough understanding of the current regulations (mandated by the USFDA and the International Conference on Harmonization), the necessity of rigorously implementing them in their groups, monitoring compliance in their and the collaborator’s organizations and incorporating this thinking in all scientific matters. continue reading

Improved Outcomes in Early Clinical Development, created and developed by IIR, brings together pharmaceutical executives, entrepreneurial scientists and venture capitalists to improve outcomes with advancements in tools and techniques and leveraging early clinical development for partnerships and investments. The event is structured for Pharmaceutical & Biotech Manufacturers in early stage development working in Biostatistics, Clinical Pharmacology, Drug Discovery, Early Drug Development, Experimental Medicine, Exploratory Medicine, Phase I Studies, PK/PD and Translational Medicine.

IDDST 2008 will offer an Olympian gathering to emphasize the pioneer explorations of basic research and technology development across therapeutic areas, to update current status all phase drug discovery and development timely. The program will also provide a profound coverage on global trend of R & D of innovative therapeutics in relation with major disease areas.

According to DRMC’s executive vice president and chief operating officer, Rob Fuller, “Passing a Joint Commission survey with no requirements for improvement is a rarity these days. The lab continues to be an area of excellence at Downey Regional, completing more than a million tests annually.”

Stephen J. Sarewitz, MD, Valley Medical Center, working group chairholder, says, "If PT is not available, laboratories should use alternative methods to periodically assess testing, because errors in the testing process can develop that may not be readily detected by routine QC. This document offers several methods that can be used to assess test performance when PT is not available."

A new wireless deep brain stimulation sensor that can monitor levels of brain chemicals has been developed by Mayo Clinic researchers and colleagues.

SANYO, a global leader in green technology, revamped and redesigned their new refrigeration systems that result in lower operating costs and efficiency for the laboratory environment. The improved SANYO ultralow freezers provide increased energy savings while minimizing the carbon footprint throughout the laboratory environment without compromising performance based on the per unit box capacity.

The ASBMR Annual Meeting, the premier meeting for bone and mineral science, will be attended by more than 5,000 clinicians and researchers from around the world. Pacific Biometrics will be exhibiting at Booth #816 at the ASBMR meeting.

The practice of pathology is at a transformation point. Molecular testing and the promise of personalized medicine will change the way patients are treated. Digital slides and other imaging technologies will change the way pathologists work. The College of American Pathologists is taking a leadership role in making sure that its members are ready for the future as central members of the patient care team.

A careers video about being a speech pathologist and studying at the University of Queensland

New Brunswick pathologists are struggling to deliver high-quality work, but they're stressed by a workload that leaves little time for anything else, says Dr. Anne O'Brien, a Saint John Regional Hospital pathologist and president of the province's pathology association.

She offered solutions to the Creaghan inquiry Wednesday about fixing problems in the health-care system. The inquiry is looking into the work of Dr. Rajgopal Menon, who last worked in Miramichi.

Read Entire Article

A leading pathologist in the Maritimes expressed concerns Monday about the quality of small hospital laboratories, telling a public inquiry they need a stronger support system.

"My personal view is that the solo pathologistst and perhaps the two-party pathology lab in a small community are unsustainable," Dr. Godfrey Heathcote, chief of pathology and laboratory medicine at the Capital Health Centre in Halifax, testified.

continue reading